Clinical Trial Update: Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating Rebif (interferon beta-1a) with advanced MRI and immunology endpoints in multiple sclerosis has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2013-05-03